Hudson Bay Capital Management
MDNA

Hudson Bay Capital Management’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History

Hudson Bay Capital Management’s Portfolio MDNA Stock Details MDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-780,564
Closed -$223K – 995
2023
Q3 		$223K Hold
780,564
– – ﹤0.01% 625
2023
Q2 		$374K Sell
780,564
-43,483
-5% -$26.9K ﹤0.01% 639
2023
Q1 		$536K Sell
824,047
-110,300
-12% -$68.7K ﹤0.01% 622
2022
Q4 		$439K Sell
934,347
-65,653
-7% -$40.1K ﹤0.01% 726
2022
Q3 		$830K Buy
+1,000,000
New +$1.13M 0.01% 864

Other funds holding MDNA

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Hudson Bay Capital Management's MDNA Position: Q4 2023 in Review

Hudson Bay Capital Management sold out of Medicenna Therapeutics Corp. Common Shares (MDNA) in Q4 2023, closing a stake of 780,564 shares — an estimated $223K sold.

Hudson Bay Capital Management first reported a position in MDNA in Q3 2022 and held it in 5 quarters. The position peaked at $830K in Q3 2022. 3 funds tracked by Wall St. Rank hold MDNA as of Q4 2023.

  • Hudson Bay Capital Management reported no remaining Medicenna Therapeutics Corp. Common Shares position as of Q4 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 780,564 Medicenna Therapeutics Corp. Common Shares shares in Q4 2023, an estimated $223K.
  • Hudson Bay Capital Management first reported a position in Medicenna Therapeutics Corp. Common Shares in Q3 2022 and held it in 5 quarters.
  • Hudson Bay Capital Management's Medicenna Therapeutics Corp. Common Shares position peaked at $830K in Q3 2022.
  • 3 funds tracked by Wall St. Rank held Medicenna Therapeutics Corp. Common Shares as of Q4 2023.

Based on Hudson Bay Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.